Q4 2024 Earnings Call Transcript February 26, 2025 Theravance Biopharma, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $0.26. Operator: Ladies and gentlemen, good ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback